# Sharon Pan

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/sharon-pan/

## Facts

| Field | Value |
| --- | --- |
| Citations | 532 |
| Field | Inflammatory mediators and NSAID effects |
| h-index | 11 |
| i10-index | 12 |
| Last Known Institution | The University of Texas Health Science Center at Houston |
| OpenAlex ID | https://openalex.org/A5111543040 |
| Works | 26 |

## Researcher papers

- [A permanent human cell line (EA.hy926) preserves the characteristics of endothelin converting enzyme from primary human umbilical vein endothelial cells](https://scholariq.org/papers/a-permanent-human-cell-line-ea-hy926-preserves-the-characteristics-of-endothelin/)
- [Cardiovascular Safety of the Cyclooxygenase-2 Selective Inhibitors Parecoxib and Valdecoxib in the Postoperative Setting: An Analysis of Integrated Data](https://scholariq.org/papers/cardiovascular-safety-of-the-cyclooxygenase-2-selective-inhibitors-parecoxib-and/)
- [Safety and efficacy of ertugliflozin in Asian patients with type 2 diabetes mellitus inadequately controlled with metformin monotherapy: VERTIS Asia](https://scholariq.org/papers/safety-and-efficacy-of-ertugliflozin-in-asian-patients-with-type-2-diabetes/)
- [Clinical Characterization and the Caregiver Burden of Dementia in China](https://scholariq.org/papers/clinical-characterization-and-the-caregiver-burden-of-dementia-in-china/)
- [Novel Selective Quinazoline Inhibitors of Endothelin Converting Enzyme-1](https://scholariq.org/papers/novel-selective-quinazoline-inhibitors-of-endothelin-converting-enzyme-1/)
- [Ectopic fibroblast growth factor receptor 1 promotes inflammation by promoting nuclear factor-κB signaling in prostate cancer cells](https://scholariq.org/papers/ectopic-fibroblast-growth-factor-receptor-1-promotes-inflammation-by-promoting/)
- [Efficacy, Safety, and Exposure of Apixaban in Patients with High Body Weight or Obesity and Venous Thromboembolism: Insights from AMPLIFY](https://scholariq.org/papers/efficacy-safety-and-exposure-of-apixaban-in-patients-with-high-body-weight-or/)
- [Analgesic effectiveness of celecoxib and diclofenac in patients with osteoarthritis of the hip requiring joint replacement surgery: a 12-week, multicenter, randomized, double-blind, parallel-group, double-dummy, noninferiority study](https://scholariq.org/papers/analgesic-effectiveness-of-celecoxib-and-diclofenac-in-patients-with/)
- [Intramuscular Ziprasidone Versus Haloperidol for Managing Agitation in Chinese Patients With Schizophrenia](https://scholariq.org/papers/intramuscular-ziprasidone-versus-haloperidol-for-managing-agitation-in-chinese/)
- [Efficacy and Safety of Celecoxib in Chinese Patients with Ankylosing Spondylitis: A 6-Week Randomized, Double-Blinded Study with 6-Week Open-Label Extension Treatment](https://scholariq.org/papers/efficacy-and-safety-of-celecoxib-in-chinese-patients-with-ankylosing-spondylitis/)
- [The burden of caring for dementia patients: caregiver reports from a cross-sectional hospital-based study in China](https://scholariq.org/papers/the-burden-of-caring-for-dementia-patients-caregiver-reports-from-a-cross/)

## Researcher topics

- [Inflammatory mediators and NSAID effects](https://scholariq.org/topics/inflammatory-mediators-and-nsaid-effects/)
- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Anesthesia and Pain Management](https://scholariq.org/topics/anesthesia-and-pain-management/)
- [Nitric Oxide and Endothelin Effects](https://scholariq.org/topics/nitric-oxide-and-endothelin-effects/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)

## Researcher university

- [The University of Texas Health Science Center at Houston](https://scholariq.org/institutions/the-university-of-texas-health-science-center-at-houston/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.